Dr. Houten’s work on substrate reduction therapy for GA1 and its implications for related pathways such as PDE offers a glimpse into the future of treatment for rare genetic disorders.

We are thrilled to extend a warm invitation to all of you for an upcoming Zoom meeting designed to bring us closer together.

We’re excited to share a unique opportunity for you to contribute directly to the future of PDE research.

Big news – we’re hosting our FIRST webinar on Pyridoxine-Dependent Epilepsy (PDE) research on January 25th, and you’re invited!

This blog post introduces the CHARLIE Consortium, a group of researchers dedicated to studying Pyridoxine-Dependent Epilepsy (PDE).

As we head into 2024, we have compiled a list of events we would like to host in the New Year.